Evaluation of the Effects of Virtual Reality on Preoperative Anxiety in Refractive Surgery

NCT ID: NCT07050498

Last Updated: 2025-07-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

68 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-09-18

Study Completion Date

2026-09-18

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this study is to determine to what extent the use of a software application prior to refractive surgery involving multisensory immersion (visual and auditory) in a hypnotic and relaxing sound and visual environment can reduce anxiety levels.

The assessment of preoperative anxiety levels will be based on the administration of a psychometric scale (APAIS scale) and the measurement of salivary cortisol, which is a sensitive marker of the patient's stress level.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a prospective, randomized, open-label, single-center study conducted on two parallel groups of patients undergoing refractive surgery (virtual reality preoperative conditioning or routine preoperative procedure). Therapeutic benefit is based on the assessment of preoperative anxiety using the APAIS scale.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Refractive Disorders

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Single-center, prospective, randomized, open-label study on two parallel groups of patients
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Virtual reality

Preoperative conditioning by virtual reality + Routine preoperative procedure (local anesthesia)

Group Type EXPERIMENTAL

Virtual reality

Intervention Type DEVICE

Virtual reality hypnosis software applications are Class I medical devices according to Rule 12 of Directive 93/42/EC. They allow, through a virtual reality headset and headphones, to immerse the patient in a hypnotic sound and visual environment. Several visual scenarios can be proposed, allowing the patient to virtually travel to a beach, the seabed, on an alpine walk, etc.).

The HypnoVR Biofeedback virtual reality device is provided by the HypnoVR company.

Usual care

Routine preoperative procedure (local anesthesia)

Group Type ACTIVE_COMPARATOR

Usual Care Group

Intervention Type PROCEDURE

Routine preoperative procedure (local anesthesia)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Virtual reality

Virtual reality hypnosis software applications are Class I medical devices according to Rule 12 of Directive 93/42/EC. They allow, through a virtual reality headset and headphones, to immerse the patient in a hypnotic sound and visual environment. Several visual scenarios can be proposed, allowing the patient to virtually travel to a beach, the seabed, on an alpine walk, etc.).

The HypnoVR Biofeedback virtual reality device is provided by the HypnoVR company.

Intervention Type DEVICE

Usual Care Group

Routine preoperative procedure (local anesthesia)

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient aged 18 years or older,
* Patient who has read and signed the consent form for participation in the study after a reflection period (between 10 and 45 minutes)
* Patient who is a candidate for refractive surgery

Exclusion Criteria

* Contraindication to virtual reality (uncontrolled epilepsy, hearing impairment)
* Pregnant or breastfeeding patient
* Cushing's disease, Addison's disease, hypo- or hyperthyroidism
* Patient treated with topical or systemic corticosteroids
* Patient treated with neuroleptics, anxiolytics, or antidepressants
* Patient under legal protection, guardianship, or curatorship
* Patient participating in another blinded research study
* Patient not affiliated with the French social security system
* Patient unable to understand the information provided and/or give written informed consent: dementia, psychosis, impaired consciousness, non-French-speaking patient
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

GCS Ramsay Santé pour l'Enseignement et la Recherche

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Clinique Monticelli

Marseille, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Louis HOFFART, MD

Role: primary

04 91 16 22 22 ext. 33

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2023-A01771-44

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.